Conference abstract · 12 Sep 2016
Conference abstractPublished 28 Sep 2015
Stem cells in immunology
University of Texas School of Medicine at Houston, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Totipotent and pluripotent stem cells (e.g. ESCs or iPSCs) and adult tissue derived stem cells have been studied for many years. Stem cell transplantation has been considered a top priority for use to treat a variety of disease states and for various tissue regeneration regimes. Various autologous stem cells have been successfully used in clinical trials, though the scarcity of stem cells has limited their application. Allogeneic derived stem cells are a potential stem cell source; however, this remains a major challenge due to their potential to trigger an immune response or rejection after transplantation. Through several years of investigation, we have discovered and isolated a novel type of muscle derived small-size stem cells (Mu3SCs) from both mice and human tissues. These Mu3SCs have been characterized as being small in size, capable of multipotent differentiation and demonstrate a naturally aggressive migration capacity. We discovered that Mu3SCs were able to survive, proliferate and differentiate within a variety of tissues and are capable of engrafting throughout the skeletal muscles of mdx mice, a dystrophic mouse model of human Duchenne muscular dystrophy, via intravenous injection. We also demonstrated that GFP pre-labeled Mu3SCs remained in the blood stream for up to three weeks. We thus hypothesized that a percentage of small in size stem cells within the general stem cell populations that are “immune-privileged”, since the Mu3SCs have the ability to escape immunological recognition in the transplanted host, which is essential for inducing immunological tolerance.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 26 Jan 2022
Current State of Cell Treatment and Stem Cell Therapy in Immunology
Article · 22 May 2024
Paracrine Secretions and Immunological Activities of Human Mesenchymal Stem Cells: The Key Regenerative Factors of Microenvironment
Perspective · 29 Sep 2021
Tumor Immunology and Immunotherapy: Stem Cells in Benign Tumors
Opinion · 28 Jul 2022
Antigen receptor of T-cell therapy, infectious complications, immune reconstruction and hematopoietic stem cell transplantation of COVID-19 chimeric.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectGenetics & Molecular Biology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Yong Li”
